| Literature DB >> 27229468 |
Marcio Silva Miguel Lima1, Hector R Villarraga2, Maria Cristina Donadio Abduch3, Marta Fernandes Lima3, Cecilia Beatriz Bittencourt Viana Cruz3, Marcio Sommer Bittencourt3, Mariana Callil Voos3, Joao Cesar Nunes Sbano3, Wilson Mathias3, Jeane Mike Tsutsui3.
Abstract
BACKGROUND: Chagas disease (CD) is a frequent cause of dilated cardiomyopathy (CMP) in developing countries, leading to clinical heart failure and worse prognosis. Therefore, the development and evolution of this CMP has always been a major topic in numbers of previous studies. A comprehensive echocardiographic study of left ventricular (LV) mechanics, fully assessing myocardial contraction, has never been done before. This could help characterize and improve the understanding of the evolution of this prevalent CMP.Entities:
Keywords: Cardiac mechanics; Cardiomyopathies; Speckle tracking echocardiography; Strain
Mesh:
Year: 2016 PMID: 27229468 PMCID: PMC4882839 DOI: 10.1186/s12947-016-0062-7
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Fig. 1Speckle tracking echocardiography. Zoom image of myocardial ultrassonographic appearance, with the speckles (a). Main orientations of LV contration: R, radial; C, circumferential; L, longitudinal (b). Representation of LV twist – clockwise rotation at the basis and counterclockwise at the apex (c). Example of myocardial mechanics analysis (d)
Clinical and demographic characteristics of groups
| Variables | Chagas | Controls | |||||
|---|---|---|---|---|---|---|---|
| Ch1A ( | Ch1B ( | Ch2 ( | Ch3 ( | C1 ( | C2 ( | C3 ( | |
| Age (y)a | 56 ± 7c | 54 ± 12c | 56 ± 12 | 56 ± 9 | 37 ± 12 | 47 ± 9 | 50 ± 11 |
| Gender Mb | 1 (12 %) | 4 (31 %) | 8 (47 %) | 3 (67 %) | 25 (43 %) | 3 (43 %) | 10 (53 %) |
| Weight (Kg)a | 66.3 ± 10.6 | 67.5 ± 12.5 | 68.3 ± 12.3 | 65.2 ± 8.6 | 73.1 ± 15.9 | 69.5 ± 14.6 | 69.8 ± 16.2 |
| Height (cm)a | 157 ± 12d | 160 ± 10d | 165 ± 8 | 162 ± 6 | 169 ± 9 | 162 ± 10 | 164 ± 12 |
| BS (m2)a | 1.66 ± 0.19 | 1.70 ± 0.18 | 1.64 ± 0.18 | 1.70 ± 0.12 | 1.83 ± 0.21 | 1.74 ± 0.21 | 1.75 ± 0.25 |
| BMI (kg/m2)a | 26.9 ± 3.5 | 26.6 ± 4.8 | 25.0 ± 3.0 | 24.8 ± 3.0 | 25.4 ± 4.1 | 26.2 ± 4.4 | 25.6 ± 3.9 |
| SAHb | 4 (50.0 %)e | 5 (38.5 %)e | 5 (29.4 %) | 4 (44.4 %) | 0 (0 %) | 1 (14.3 %) | 8 (42.1 %) |
| DMb | 1 (12.5 %) | 1 (7.7 %) | 1 (5.9 %) | 1 (11.1 %) | 0 (0 %) | 1 (14.3 %) | 1 (5.3 %) |
| DLPb | 2 (25.0 %)f | 4 (30.8 %)f | 4 (23.5 %) | 4 (44.4 %) | 1 (1.7 %) | 1 (14.3 %) | 4 (21.1 %) |
| Smokerb | 0 (0 %) | 0 (0 %) | 0 (0 %) | 1 (11.1 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) |
| FC CHF (NYHA)b | |||||||
| I | 1 (12.5 %)g | 7 (53.8 %)g | 11 (64.7 %) | 5 (55.5 %) | 0 (0 %) | 3 (42.9 %) | 11 (57.9 %) |
| II | 0 (0 %) | 1 (7.7 %) | 5 (29.4 %) | 4 (44.4 %) | 0 (0 %) | 3 (42.9 %) | 7 (36.8 %) |
| III | 0 (0 %) | 0 (0 %) | 1 (5.9 %) | 0 (0 %) | 0 (0 %) | 1 (14.3 %) | 1 (5.3 %) |
| IV | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) |
| Therapyb | |||||||
| Digital | 0 (0 %) | 0 (0 %) | 0 (0 %) | 3 (3.3 %) | 0 (0 %) | 2 (28.6 %) | 5 (26.3 %) |
| ACEi | 3 (37.5 %)h | 4 (30.8 %)h | 14 (82.4 %) | 7 (77.8 %) | 0 (0 %) | 3 (42.9 %) | 15 (78.9 %) |
| Bblock | 1 (12.5 %) | 1 (7.7 %) | 12 (70.6 %) | 9 (100 %) | 2 (3.4 %) | 6 (85.7 %) | 19 (100 %) |
| ARB | 0 (0 %) | 3 (23.1 %)i | 2 (11.8 %) | 2 (22.2 %) | 0 (0 %) | 3 (42.9 %) | 4 (21.1 %) |
| Ca++block | 0 (0 %) | 1 (7.7 %) | 1 (5.9 %) | 1 (11.1 %) | 0 (0 %) | 0 (0 %) | 1 (5.3 %) |
| Diuretics | 3 (37.5 %)j | 2 (18.2 %)j | 7 (46.7 %) | 5 (100 %) | 0 (0 %) | 2 (40 %) | 12 (85.7 %) |
| Aldost. Ant. | 0 (0 %) | 0 (0 %) | 8 (47.1 %) | 6 (66.7 %) | 0 (0 %) | 5 (71.4 %) | 12(63.2 %) |
| Hemodynamics | |||||||
| HR (bpm) | 63.3 ± 4.1 | 61.9 ± 11.7k | 63.7 ± 10.9 | 69.4 ± 9.7 | 71.1 ± 11.0 | 64.6 ± 12.4 | 78.6 ± 15.4 |
| SAP (mmHg) | 132.0 ± 12.1 | 122.5 ± 12.3 | 122.4 ± 15.5 | 111.4 ± 18.0 | 122.4 ± 11.7 | 118.0 ± 28.5 | 121.7 ± 15.6 |
| DAP (mmHg) | 79.1 ± 2.7 | 73.9 ± 12.7 | 74.0 ± 11.5 | 70.1 ± 12.6 | 74.6 ± 12.8 | 70.6 ± 12.8 | 79.5 ± 15.0 |
BS body surface, BMI body mass index, SAH systemic arterial hypertension, DM diabetes mellitus, DLP dyslipidemia, FC CHF NYHA functional class of congestive heart failure, NYHA New York Heart Association, ACEi inhibitor of angiotensin converting enzyme, β block beta blocker; ARB angiotensin II receptor blocker, Ca ++ block calcium channel blocker; Aldost Ant aldosterone antagonist, HR heart rate, SAP systolic arterial pressure, DAP diastolic arterial pressure
aContinuous variables expressed as mean ± SD. bCategorical variables expressed as frequency (proportion)
cTukey test, p < 0.001, vs. C1
dTukey; Ch1A, Ch1B p = 0.03 and p = 0.04, vs. C1
eFisher’s exact test; Ch1A and Ch1B, p < 0.001, vs. C1
fFisher’s exact test; Ch1A and Ch1B, p = 0.03; vs. C1
gFisher’s exact test; Ch1A and Ch1B, p < 0.001, vs. C1
hFisher’s exact test; Ch1A and Ch1B, p < 0.001, vs. C1
iFisher’s exact test, p = 0.04, vs. C1
jFisher’s exact test; Ch1A and Ch1B, p = 0.01, vs. C1
kTukey test, p < 0.02, vs. C1
Echocardiographic variables
| Variables | Chagas | Controls | |||||
|---|---|---|---|---|---|---|---|
| Ch1A ( | Ch1B ( | Ch2 ( | Ch3 ( | C1 ( | C2 ( | C3 ( | |
| LA (mm)a | 34.4 ± 2.3 | 32.2 ± 4.7 | 40.7 ± 4.1 | 46.6 ± 6.5 | 33.6 ± 3.2 | 37.9 ± 6.8 | 44.1 ± 5.1 |
| LVDD (mm)a | 47.4 ± 3.9 | 47.1 ± 4.2 | 62.4 ± 5.7 | 74.9 ± 5.8c | 46.7 ± 4.5 | 50.7 ± 7.6 | 67.0 ± 4.9 |
| LVSD(mm)a | 31.3 ± 3.9 | 33.5 ± 4.8 | 50.5 ± 7.2 | 66.1 ± 5.7 | 30.5 ± 3.2 | 45.9 ± 7.0 | 59.5 ± 5.1 |
| LVFS (%)a | 34.3 ± 3.1 | 33.3 ± 4.9 | 19.3 ± 6.0 | 11.2 ± 3.7 | 35.2 ± 2.6 | 19.0 ± 9.4 | 11.2 ± 2.6 |
| LVEDV (ml)a | 82.5 ± 24.6d | 74.0 ± 29.8 | 149.5 ± 37.0 | 262.0 ± 61.7 | 108.7 ± 28.2 | 147.1 ± 67.8 | 216.4 ± 63.4 |
| LVESV (ml)a | 29.5 ± 11.8 | 38.5 ± 15.3 | 84.6 ± 24.0 | 191.6 ± 43.8 | 39.6 ± 13.2 | 87.0 ± 45.8 | 167.1 ± 49.7 |
| LVEF (%)a | 65.0 ± 4.3 | 61.7 ± 5.5 | 43.8 ± 6.6 | 26.6 ± 3.9 | 64.3 ± 4.6 | 42.1 ± 6.0 | 23.0 ± 6.1 |
| Diast. Func.e | |||||||
| Normal | 5 (62.5 %) | 9 (69.7 %) | 1 (5.9 %) | 0 (0 %) | 54 (93.1 %) | 2 (28.6 %) | 0 (0 %) |
| Grade I | 3 (37.5 %)e | 4 (30.8 %)e | 11 (64.7 %) | 5 (55.6 %) | 4 (6.9 %) | 5 (71.4 %) | 8 (42.1 %) |
| Grade II | 0 (0 %) | 0 (0 %) | 5 (29.4 %) | 4 (44.4 %) | 0 (0 %) | 0 (0 %) | 5 (26.3 %) |
| Grade III | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 1 (5.3 %) |
| Grade IV | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 5 (26.3 %) |
| E Vel (m/s)a | 0.73 ± 0.17 | 0.78 ± 0.15 | 0.65 ± 0.26 | 0.79 ± 0.34 | 0.82 ± 0.16 | 0.61 ± 0.16 | 0.76 ± 0.24 |
| E DT (ms)a | 240.6 ± 37.3f | 214.5 ± 36.3 | 274.6 ± 81.3 | 233.6 ± 60.5 | 190.8 ± 33.3 | 238.6 ± 61.8 | 200.9 ± 107.4 |
| A Vel (m/s)a | 0.71 ± 0.16g | 0.69 ± 0.17g | 0.67 ± 0.27 | 0.69 ± 0.18 | 0.48 ± 0.12 | 0.71 ± 0.19 | 0.60 ± 0.33 |
| S’ Vel (cm/s)a | 0.06 ± 0.01h | 0.05 ± 0.01h | 0.05 ± 0.01 | 0.04 ± 0.01 | 0.08 ± 0.02 | 0.05 ± 0.01 | 0.03 ± 0.01 |
| E’ Vel (cm/s)a | 0.06 ± 0.02i | 0.08 ± 0.02i | 0.05 ± 0.01 | 0.03 ± 0.01 | 0.11 ± 0.02 | 0.07 ± 0.01 | 0.04 ± 0.02 |
| A’ Vel (cm/s)a | 0.09 ± 0.03 | 0.08 ± 0.02 | 0.07 ± 0.02 | 0.06 ± 0.02 | 0.09 ± 0.02 | 0.06 ± 0.01 | 0.04 ± 0.02 |
| E/E’a | 12.0 ± 4.3g | 11.8 ± 5.3g | 13.4 ± 4.7 | 23.9 ± 11.1 | 7.9 ± 1.7 | 9.8 ± 2.5 | 23.4 ± 11.0 |
| MR Gradeb | |||||||
| Absent/Trivial | 6 (75.0 %) | 9 (69.2 %) | 4 (23.5 %) | 0 (0 %) | 55 (94.8 %) | 2 (28.6 %) | 1 (5.3 %) |
| Mild | 2 (25.0 %)j | 4 (30.8 %)j | 9 (52.9 %) | 3 (33.3 %) | 3 (5.2 %) | 4 (57.1 %) | 13 (68.4 %) |
| Moderate | 0 (0 %) | 0 (0 %) | 3 (17.6 %) | 2 (22.2 %) | 0 (0 %) | 1 (14.3 %) | 4 (21.1 %) |
| Severe | 0 (0 %) | 0 (0 %) | 1 (5.9 %) | 4 (44.4 %) | 0 (0 %) | 0 (0 %) | 1 (5.3 %) |
aContinuous numeric variables expressed as mean ± SD. bOrdinal variables expressed as number of patients (percentage). LA, left atrium; LVDD, left ventricular diastolic diameter, LVSD, left ventricular systolic diameter; LVFS, left ventricular fractional shortening; LVEDV, end-diastolic volume of the left ventricle; LVESV, end-systolic volume of the left ventricle; LVEF, left ventricular ejection fraction; E Vel, E wave velocity, TD E, deceleration time of E wave; A Vel, A wave velocity; S' Vel, S’ wave velocity; E’ Vel, E’ wave velocity; MR degree, degree of mitral regurgitation
cStudent t-test, p = 0.01; vs. C3
dTukey test, p = 0.04, vs. C1
eFisher’s exact test; Ch1A and Ch1B, p = 0.03; vs. C1
fTukey test, p = 0.01, vs. C1
gTukey; Ch1A and Ch1B, p < 0.05, vs. C1
hTukey; Ch1A and Ch1B, p < 0.01, vs. C1
iTukey; Ch1A and Ch1B, p < 0.05, vs. C1
jTukey; Ch1A and Ch1B, p = 0.01, vs. C1
Global values of left ventricular mechanical contraction analysis obtained from apical views (longitudinal, A4C and A2C)
| Variables | Chagas | Controles | |||||
|---|---|---|---|---|---|---|---|
| Ch1A ( | Ch1B ( | Ch2 ( | Ch3 ( | C1 ( | C2 ( | C3 ( | |
| APLAX | |||||||
| LVel (cm/s) | 3.28 ± 0.52a | 3.81 ± 0.61 | 3.24 ± 0.77 | 3.22 ± 1.02d | 4.42 ± 0.94 | 3.45 ± 1.26 | 2.52 ± 0.70 |
| LS (%) | −21.68 ± 2.73 | −21.57 ± 2.58 | −13.86 ± 2.83 | −9.82 ± 2.96 | −20.79 ± 2.45 | −14.69 ± 2.13 | −7.89 ± 2.92 |
| LSR (1/s) | −1.02 ± 0.36 | −1.07 ± 0.36 | −0.85 ± 0.23 | −0.65 ± 0.11 | −1.12 ± 0.22 | −0.86 ± 0.18 | −0.62 ± 0.18 |
| LD (mm) | 9.49 ± 1.70 | 9.47 ± 1.50 | 6.75 ± 1.77 | 6.25 ± 1.86e | 9.60 ± 1.51 | 7.46 ± 1.10 | 4.21 ± 1.65 |
| A4C | |||||||
| LVel (cm/s) | 3.54 ± 0.49b | 4.17 ± 0.60 | 3.33 ± 0.77 | 2.90 ± 1.03 | 4.54 ± 0.92 | 3.38 ± 0.73 | 2.73 ± 0.91 |
| LS (%) | −23.16 ± 2.88 | −21.06 ± 2.35 | −15.54 ± 2.88 | −9.96 ± 2.34 | −21.16 ± 2.52 | −14.73 ± 2.32 | −8.48 ± 3.04 |
| LSR (1/s) | −1.14 ± 0.17 | −1.13 ± 0.19 | −0.86 ± 0.16 | −0.63 ± 0.16 | −1.20 ± 0.16 | −0.83 ± 0.18 | −0.71 ± 0.23 |
| LD (mm) | 10.80 ± 2.03 | 10.39 ± 1.41 | 8.44 ± 1.48 | 7.73 ± 2.02f | 10.75 ± 1.60 | 8.28 ± 1.54 | 4.83 ± 2.15 |
| A2C | |||||||
| LVel (cm/s) | 3.19 ± 0.58c | 3.47 ± 0.50c | 3.01 ± 0.56 | 2.86 ± 0.78 | 4.30 ± 0.85 | 3.33 ± 0.72 | 2.54 ± 0.65 |
| LS (%) | −22.42 ± 2.80 | −22.36 ± 2.22 | −16.02 ± 2.96 | −10.31 ± 1.36 | −22.28 ± 2.82 | −15.63 ± 2.42 | −8.32 ± 2.90 |
| LSR (1/s) | −1.05 ± 0.14g | −1.17 ± 0.12 | −0.83 ± 0.16 | −0.69 ± 0.10 | −1.21 ± 0.18 | −0.84 ± 0.14 | −0.64 ± 0.13 |
| LD (mm) | 10.42 ± 1.65 | 10.67 ± 1.60 | 8.72 ± 1.40 | 6.46 ± 1.52 h | 11.09 ± 1.91 | 8.41 ± 1.90 | 4.86 ± 1.53 |
| GLOBAL | |||||||
| LVel (cm/s) | 3.33 ± 0.44i | 3.81 ± 0.50i | 3.20 ± 0.63 | 3.00 ± 0.79 | 4.43 ± 0.78 | 3.39 ± 0.77 | 2.60 ± 0.67 |
| LS (%) | −22.42 ± 2.57 | −21.67 ± 1.95 | −15.14 ± 2.70 | −10.03 ± 1.96 | −21.41 ± 2.27 | −15.01 ± 1.95 | −8.23 ± 2.82 |
| LSR (1/s) | −1.07 ± 0.17 | −1.12 ± 0.13 | −0.85 ± 0.15 | −0.66 ± 0.11 | −1.20 ± 0.17 | −0.84 ± 0.13 | −0.66 ± 0.16 |
| LD (mm) | 10.23 ± 1.63 | 10.17 ± 1.36 | 7.97 ± 1.32 | 6.48 ± 1.57j | 10.48 ± 1.45 | 8.05 ± 1.30 | 4.63 ± 1.6 |
Data expressed as mean ± SD. APLAX apical longitudinal axis, A4C apical, 4-chambers, A2C apical 2-chambers, LVel longitudinal velocity, LS longitudinal strain, LSR longitudinal strain rate, LD longitudinal displacement, GLOBAL refers to the average values of the 3 incidences (APLAX, A4C and A2C)
aTukey, p = 0.02; vs. C1
bTukey, p = 0.007; vs. C1
cTukey; Ch1A, p = 0.01, and Ch1B, p = 0.03; vs. C1
dStudent’s t-test, p = 0.04, vs. C3
eStudent t-test, p = 0.007; vs. C3
fStudent t-test, p = 0.04; vs. C3
gTukey test, p = 0.03; vs. C1
hStudent t-test, p = 0.02; vs. C3
iTukey; Ch1A, p <0.001, and Ch1B, p = 0.02; vs. C1
jStudent t-test, p = 0.01; vs. C3
Global values of ventricular mechanical contraction analysis obtained from left ventricular short axis (basal, middle and apical)
| Variables | Chagas | Controls | |||||
|---|---|---|---|---|---|---|---|
| Ch1A ( | Ch1B ( | Ch2 ( | Ch3 ( | C1 ( | C2 ( | C3 ( | |
| SAX – MV | |||||||
| CS (%) | −21.11 ± 4.57 | −18.79 ± 3.47 | −13.12 ± 2.67 | −9.84 ± 2.52 | −18.42 ± 2.96 | −13.38 ± 2.28 | −8.83 ± 2.81 |
| RS (%) | 48.92 ± 16.90 | 53.89 ± 21.25 | 34.23 ± 22.37 | 24.84 ± 11.48 | 47.50 ± 14.64 | 26.01 ± 15.36 | 20.91 ± 13.38 |
| CSR (1/s) | −1.56 ± 0.18 | −1.50 ± 0.38 | −1.04 ± 0.22 | −0.82 ± 0.18 | −1.47 ± 0.29 | −1.17 ± 0.26 | −0.83 ± 0.28 |
| RSR (1/s) | 2.00 ± 0.35 | 2.12 ± 0.58 | 1.46 ± 0.50 | 1.44 ± 0.46 | 2.00 ± 0.44 | 1.73 ± 0.44 | 1.50 ± 0.62 |
| RD (mm) | 6.93 ± 1.37 | 6.45 ± 1.14 | 4.84 ± 1.16 | 4.39 ± 1.43 | 6.44 ± 1.03 | 4.64 ± 0.96 | 3.67 ± 1.23 |
| Rot (o) | −8.03 ± 4.64 | −6.15 ± 2.55 | −4.84 ± 2.41 | −2.50 ± 2.38 | −5.86 ± 2.38 | −4.66 ± 1.63 | −3.35 ± 2.50 |
| RotVel (o/s) | −66.66 ± 12.87 | −52.61 ± 13.66 | −41.13 ± 18.90 | −27.85 ± 21.27 | −64.91 ± 21.11 | −48.07 ± 11.20 | −33.33 ± 19.40 |
| SAX – PM | |||||||
| CS (%) | −20.61 ± 4.43 | −18.49 ± 2.38 | −12.96 ± 3.52 | −9.13 ± 1.67 | −19.05 ± 3.52 | −12.42 ± 2.30 | −8.03 ± 2.10 |
| RS (%) | 57.19 ± 20.60 | 50.00 ± 18.72 | 37.92 ± 17.35 | 17.11 ± 11.38 | 50.63 ± 15.37 | 28.67 ± 15.21 | 12.88 ± 8.70 |
| CSR (1/s) | −1.48 ± 0.24 | −1.36 ± 0.24 | −1.07 ± 0.26 | −0.82 ± 0.33 | −1.41 ± 0.25 | −1.03 ± 0.18 | −0.73 ± 0.18 |
| RSR (1/s) | 2.00 ± 0.46 | 1.92 ± 0.59 | 1.52 ± 0.43 | 1.26 ± 0.45 | 1.85 ± 0.45 | 1.57 ± 0.49 | 1.23 ± 0.62 |
| RD (mm) | 7.14 ± 1.75 | 6.20 ± 0.76 | 4.90 ± 1.49 | 3.47 ± 0.80 | 6.43 ± 1.06 | 4.40 ± 0.83 | 3.14 ± 1.17 |
| SAX – AP | |||||||
| CS (%) | −27.64 ± 6.06 | −25.14 ± 4.06 | −17.13 ± 4.04 | −9.26 ± 4.96 | −26.20 ± 6.41 | −15.22 ± 3.55 | −7.48 ± 3.25 |
| RS (%) | 24.20 ± 14.43 | 15.44 ± 14.01 | 16.57 ± 12.70 | 3.62 ± 10.61 | 25.92 ± 20.46 | 18.01 ± 18.51 | 7.86 ± 6.43 |
| CSR (1/s) | −1.51 ± 0.34 | −1.63 ± 0.33 | −1.09 ± 0.38 | −0.71 ± 0.27 | −1.76 ± 0.43 | −1.10 ± 0.32 | −0.68 ± 0.26 |
| RSR (1/s) | 1.32 ± 0.46 | 1.46 ± 0.64 | 1.19 ± 0.53 | 1.13 ± 0.77 | 1.53 ± 0.79 | 1.13 ± 0.54 | 0.87 ± 0.37 |
| RD (mm) | 4.89 ± 1.14 | 4.55 ± 1.18 | 4.13 ± 1.28 | 2.49 ± 0.83a | 5.43 ± 1.38 | 3.47 ± 0.99 | 1.54 ± 1.18 |
| Rot (o) | 12.73 ± 2.95 | 12.89 ± 3.91 | 6.47 ± 3.71 | 3.24 ± 4.51 | 13.15 ± 4.18 | 6.05 ± 2.99 | 3.00 ± 3.26 |
| RotVel (o/s) | 67.65 ± 15.52 | 80.34 ± 25.54 | 44.88 ± 15.64 | 25.65 ± 35.00 | 85.82 ± 29.84 | 47.57 ± 27.36 | 31.25 ± 20.89 |
Data expressed as mean ± SD. SAX-MV short axis, mitral valve, SAX-PM short axis, papillary muscles, SAX-AP short axis, apical, CS circumferential strain, RS radial strain, CSR circumferential strain rate, RSR radial strain rate, RD radial displacement, Rot rotation, Rot Vel rotational velocity
aStudent t-test, p = 0.04, vs. C3
Results of left ventricular twist and torsion
| Chagas | Controls | ||||||
|---|---|---|---|---|---|---|---|
| Variables | Ch1A ( | Ch1B ( | Ch2 ( | Ch3 ( | C1 ( | C2 ( | C3 ( |
|
| 20.77 ± 6.56 | 19.03 ± 3.47 | 11.31 ± 4.14 | 5.75 ± 6.24 | 19.00 ± 4.71 | 10.71 ± 1.87 | 6.35 ± 3.79 |
| TwVel (o/s) | 134.31 ± 21.70 | 132.95 ± 29.81 | 86.01 ± 24.04 | 53.50 ± 54.28 | 150.73 ± 39.54 | 95.63 ± 33.81 | 64.60 ± 26.75 |
| Torsion(o/cm) | 2.64 ± 0.83 | 2.37 ± 0.65 | 1.30 ± 0.51 | 0.65 ± 0.71 | 2.28 ± 0.61 | 0.99 ± 0.55 | 0.78 ± 0.46 |
| T Vel(o/s.cm) | 17.14 ± 2.89 | 16.59 ± 5.45 | 9.66 ± 2.85 | 6.32 ± 6.16 | 18.00 ± 4.70 | 10.12 ± 5.06 | 7.37 ± 3.03 |
Data expressed as mean ± SD. Tw Vel twist velocity, T Vel torsional velocity
Analysis of mid-left ventricular radial displacement
| Varibles | Chagas | Controls | |||||
|---|---|---|---|---|---|---|---|
| Ch1A ( | Ch1B ( | Ch2 ( | Ch3 ( | C1 ( | C2 ( | C3 ( | |
| RD (mm) | |||||||
| AntSept | 8.24 ± 2.13 | 7.52 ± 1.46 | 6.60 ± 3.47 | 5.88 ± 2.25a | 7.15 ± 1.51 | 4.13 ± 2.00 | 2.39 ± 1.09 |
| Ant | 7.21 ± 2.26 | 6.54 ± 1.86 | 6.62 ± 1.82 | 5.27 ± 2.49b | 7.00 ± 1.72 | 5.72 ± 1.79 | 3.62 ± 1.50 |
| Lat | 6.13 ± 2.21 | 5.48 ± 1.91 | 4.31 ± 1.60c | 3.88 ± 2.69 | 6.32 ± 1.72 | 6.00 ± 0.93 | 4.80 ± 2.00 |
| Post | 6.09 ± 2.40 | 5.14 ± 1.55 | 3.55 ± 1.51 | 2.02 ± 0.90d | 5.80 ± 1.48 | 4.74 ± 0.78 | 3.80 ± 1.92 |
| Inf | 7.05 ± 2.20 | 5.90 ± 1.77 | 3.77 ± 2.28 | 0.92 ± 1.72e | 5.96 ± 1.57 | 3.05 ± 0.54 | 2.22 ± 1.20 |
| Sept | 8.12 ± 1.55g | 7.25 ± 1.57 | 5.50 ± 3.12f | 2.82 ± 3.03 | 6.55 ± 1.64 | 2.78 ± 1.06 | 2.00 ± 1.00 |
RD radial displacement. Numeric continuous variables expressed as mean ± SP
at-Student test; p = 0.001; vs C3
bt-Student test; p = 0.04; vs C3
ct-Student test; p = 0.02; vs C2
dt-Student test; p = 0.03; vs C3
et-Student test; p = 0.03; vs C3
ft-Student test; p = 0.004; vs C2
gANOVA/Tukey’s test; p = 0.03; vs C1
Analysis of mid-left ventricular radial strain and strain rate
| Variables | Chagas | Controls | |||||
|---|---|---|---|---|---|---|---|
| Ch1A ( | Ch1B ( | Ch2 ( | Ch3 ( | C1 ( | C2 ( | C3 ( | |
| RS (%) | |||||||
| AntSept | 48.38 ± 12.84 | 48.40 ± 15.41 | 45.89 ± 24.70 | 29.15 ± 25.06a | 44.85 ± 14.55 | 28.57 ± 15.97 | 8.79 ± 6.80 |
| Ant | 49.92 ± 18.57 | 50.64 ± 26.51 | 35.28 ± 18.42 | 18.43 ± 14.55 | 43.75 ± 14.18 | 30.06 ± 17.27 | 8.39 ± 7.80 |
| Lat | 58.15 ± 25.71 | 55.33 ± 33.18 | 30.87 ± 18.68 | 12.52 ± 11.90 | 49.90 ± 17.34 | 30.94 ± 22.50 | 13.14 ± 12.50 |
| Post | 65.07 ± 30.01 | 54.06 ± 27.20 | 32.78 ± 19.12 | 7.49 ± 8.54 | 55.53 ± 20.00 | 29.66 ± 22.76 | 17.02 ± 14.11 |
| Inf | 63.98 ± 26.45 | 48.18 ± 18.74 | 37.84 ± 18.37 | 11.09 ± 15.96 | 56.98 ± 19.69 | 26.82 ± 18.03 | 16.58 ± 12.16 |
| Sept | 57.64 ± 17.73 | 45.75 ± 17.14 | 44.86 ± 20.87b | 23.98 ± 19.59 | 53.69 ± 18.42 | 25.95 ± 11.45 | 13.36 ± 8.83 |
| RSR (1/s) | |||||||
| AntSept | 1.78 ± 0.34 | 1.87 ± 0.83 | 1.35 ± 0.62 | 1.35 ± 0.59 | 1.69 ± 0.43 | 1.70 ± 1.20 | 1.04 ± 0.86 |
| Ant | 1.81 ± 0.47 | 1.94 ± 0.85 | 1.53 ± 0.45 | 1.44 ± 0.48 | 1.75 ± 0.47 | 1.75 ± 0.68 | 1.24 ± 1.00 |
| Lat | 2.11 ± 0.59 | 2.04 ± 0.69 | 1.52 ± 0.45 | 1.41 ± 0.77 | 1.88 ± 0.49 | 1.65 ± 0.43 | 1.47 ± 0.84 |
| Post | 2.24 ± 0.68 | 1.96 ± 0.59 | 1.45 ± 0.55 | 1.08 ± 0.48 | 1.96 ± 0.51 | 1.50 ± 0.40 | 1.28 ± 0.55 |
| Inf | 2.12 ± 0.66 | 1.91 ± 0.51 | 1.50 ± 0.82 | 0.93 ± 0.31 | 1.92 ± 0.50 | 1.41 ± 0.24 | 1.22 ± 0.63 |
| Sept | 1.91 ± 0.49 | 1.89 ± 0.77 | 1.64 ± 0.58 | 1.33 ± 0.61 | 1.80 ± 0.46 | 1.42 ± 0.68 | 1.15 ± 0.58 |
Continuos variables expressed as mean ± SD
RS radial strain, RSR radial strain rate
at-Student test; p = 0.02; vs C3
bt-Student test; p = 0.04; vs C2
Fig. 2Example of a STE analysis. Patient with CD and normal LVEF. Analyzes of strain (a) and strain rate (b) in a patient with CD and preserved LVEF, apical four-chamber view. Ventricular myocardium is divided in six color-coded segments and strain/strain rate curves are displayed. Also, small boxes display color m-mode. Note a lack of deformation (worse values; yellow arrows) at the base and mid-segment of lateral wall (red and blue curves, respectively), classically affected by CD